Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000671945 | SCV000796989 | uncertain significance | Niemann-Pick disease, type A | 2018-01-08 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000671945 | SCV004205509 | likely pathogenic | Niemann-Pick disease, type A | 2023-04-25 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV005240439 | SCV005884231 | likely pathogenic | Sphingomyelin/cholesterol lipidosis | 2024-12-10 | criteria provided, single submitter | clinical testing | Variant summary: SMPD1 c.362T>C (p.Leu121Pro) results in a non-conservative amino acid change located in the saposin B type domain (IPR008139) of the encoded protein sequence. Four of four in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 251300 control chromosomes (gnomAD). c.362T>C has been reported in the literature in individuals including homozygotes affected with Niemann-Pick Disease (examples: Reunert_2015; Velez-Pinos_2023). These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 26981555, 36779112). ClinVar contains an entry for this variant (Variation ID: 556008). Based on the evidence outlined above, the variant was classified as likely pathogenic. |